Study Links Micro-Awakenings to Alzheimer's Genetic Risk
Research on over 500 people finds a higher frequency of brief nocturnal micro-awakenings in middle-aged adults is associated with a greater genetic risk

A new study analyzing the sleep of more than 500 healthy individuals has found a link between brief nighttime awakenings and genetic risk for Alzheimer's disease. The research suggests sleep analysis could one day help identify vulnerable people before symptoms appear.
Researchers from the University of Liège calculated a polygenic risk score for participants, summarizing the combined influence of genes on disease probability. The cohort included young adults aged 18 to 31 and older participants aged 50 to 69. They then correlated these risk scores with detailed sleep characteristics.
Micro-Awakenings and Genetic Risk
Among the middle-aged participants, a higher frequency of nocturnal micro-awakenings was associated with a greater genetic risk of developing Alzheimer's. These micro-awakenings are brief periods of brain activity that disrupt the sleep cycle without fully waking the sleeper. This specific link was not observed in the younger adult group.
Researcher Puneet Talwar stated in a release that these sleep disruptions are significant. "These micro-awakenings are therefore not insignificant..."
The Role of the Locus Coeruleus
The study also focused on a small brainstem region called the locus coeruleus, which is involved in wakefulness and sleep regulation. This area is one of the first where abnormal protein deposits linked to Alzheimer's appear, sometimes as early as adolescence.
Gilles Vandewalle, a co-director of the GIGA CRC In Vivo Imaging platform, explained the region's importance. "This region is difficult to observe, but it appears to play a role in the early mechanisms linked to the disease," he said in a release.
Implications for Screening and Prevention
The findings open new avenues for early screening. They suggest that analyzing sleep patterns could eventually complement existing tools for identifying at-risk individuals long before clinical symptoms manifest. Sleep could serve as an accessible, non-invasive marker.
"Sleep could become an accessible marker for the early identification of vulnerable individuals," Vandewalle noted. Lucie Leroux of the Stop Alzheimer's Foundation added that the "sleep is not only an indicator of health, but also a potential lever for intervention."
The researchers caution that these findings represent statistical associations that require further confirmation. They cannot currently predict the disease in any specific individual. However, the work shows the critical role of basic research in understanding and anticipating neurodegenerative conditions like Alzheimer's.





